STOCK TITAN

Aberdeen Group discloses 5.91% uniQure (QURE) stake in amended 13G

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

uniQure N.V. (QURE) received an updated ownership report from Aberdeen Group plc and abrdn Inc. The firms report beneficial ownership of 3,678,640 ordinary shares, representing 5.91% of uniQure’s outstanding ordinary shares.

The shares are held with shared power to vote and dispose, and no sole voting or dispositive power. The reporting parties state the holdings are maintained in the ordinary course of business and not for the purpose of changing or influencing control of uniQure.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Aberdeen Group plc
Signature:Lyn Beaton
Name/Title:Lyn Beaton, Senior Major Shareholding Reporting Analyst
Date:01/22/2026
abrdn Inc.
Signature:Lyn Beaton
Name/Title:Lyn Beaton, Senior Major Shareholding Reporting Analyst
Date:01/22/2026
Exhibit Information

Aberdeen Group plc abrdn Holdings Limited abrdn Inc. Aberdeen Group plc is the parent company. abrdn Holdings Limited is the intermediate holding company for abrdn Inc. abrdn Inc. beneficially owns on behalf of our underlying clients 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.

FAQ

What percentage of uniQure (QURE) shares does Aberdeen Group report owning?

Aberdeen Group plc and abrdn Inc. report beneficial ownership of 5.91% of uniQure’s ordinary shares. This corresponds to 3,678,640 ordinary shares of uniQure N.V., as disclosed in the amended Schedule 13G/A, based on the issuer’s outstanding share count.

How many uniQure (QURE) shares are beneficially owned by Aberdeen and abrdn?

The filing reports beneficial ownership of 3,678,640 uniQure ordinary shares. Aberdeen Group plc and abrdn Inc. have shared voting and shared dispositive power over these shares, with no sole voting or sole dispositive power reported in the Schedule 13G/A amendment.

Do Aberdeen Group and abrdn intend to influence control of uniQure (QURE)?

The reporting parties state the shares were acquired and are held in the ordinary course of business, not to influence control. They certify the holdings are not part of any transaction intended to change or influence control of uniQure N.V.

Who are the reporting persons in this uniQure (QURE) Schedule 13G/A filing?

The reporting persons are Aberdeen Group plc and abrdn Inc. Aberdeen Group plc is the parent company, abrdn Holdings Limited is the intermediate holding company, and abrdn Inc. beneficially owns the reported shares on behalf of underlying clients.

What type of uniQure (QURE) security is covered in this ownership report?

The filing covers uniQure N.V. ordinary shares with a par value of €0.05 per share. These ordinary shares are identified by CUSIP number N90064101 and form the class of securities for which beneficial ownership is being reported.

What voting and dispositive powers are reported over uniQure (QURE) shares?

Aberdeen Group plc and abrdn Inc. report shared voting and shared dispositive power over 3,678,640 shares, with no sole power. Both sole voting power and sole dispositive power are reported as zero in the Schedule 13G/A amendment.

Uniqure

NASDAQ:QURE

QURE Rankings

QURE Latest News

QURE Latest SEC Filings

QURE Stock Data

1.43B
58.43M
6.08%
96.92%
16.51%
Biotechnology
Pharmaceutical Preparations
Link
Netherlands
AMSTERDAM